Literature DB >> 27347900

Obstructive Sleep Apnea and Vascular Diseases.

Dimitrios Baltzis1, Jessie P Bakker2, Sanjay R Patel2, Aristidis Veves1.   

Abstract

Obstructive sleep apnea (OSA) affects a large proportion of adults, and is as an independent risk factor for cerebrovascular and cardiovascular disease. The repetitive airway obstruction that characterizes OSA results in intermittent hypoxia, intrathoracic pressure swings, and sleep fragmentation, which in turn lead to sympathetic activation, oxidative stress, inflammation, and endothelial dysfunction. This review outlines the associations between OSA and vascular diseases and describes basic mechanisms that may be responsible for this association, in both the micro- and macrocirculation. It also reports on interventional studies that aim to ameliorate OSA and thereby reduce vascular disease burden. © 2016 American Physiological Society. Compr Physiol 6:1519-1528, 2016.
Copyright © 2016 John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27347900     DOI: 10.1002/cphy.c150029

Source DB:  PubMed          Journal:  Compr Physiol        ISSN: 2040-4603            Impact factor:   9.090


  15 in total

1.  Shearing the brain.

Authors:  Jay M J R Carr; Philip N Ainslie
Journal:  J Appl Physiol (1985)       Date:  2020-08-27

Review 2.  Cardioprotection by intermittent hypoxia conditioning: evidence, mechanisms, and therapeutic potential.

Authors:  Robert T Mallet; Eugenia B Manukhina; Steven Shea Ruelas; James L Caffrey; H Fred Downey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-04-13       Impact factor: 4.733

3.  A dual blocker of endothelin A/B receptors mitigates hypertension but not renal dysfunction in a rat model of chronic kidney disease and sleep apnea.

Authors:  Humberto Morales-Loredo; David Jones; Adelaeda Barrera; Perenkita J Mendiola; Joshua Garcia; Carolyn Pace; Minerva Murphy; Nancy L Kanagy; Laura V Gonzalez Bosc
Journal:  Am J Physiol Renal Physiol       Date:  2019-02-27

4.  Obstructive sleep apnea is the triggering factor for massive hemoptysis : Obstructive sleep apnea and hemoptysis.

Authors:  Meral Uyar; Selim Kervancioglu; Nazan Bayram; Berna Taskin-Dogan; Ayten Filiz
Journal:  Sleep Breath       Date:  2016-12-19       Impact factor: 2.816

Review 5.  Sleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequences.

Authors:  Shahrokh Javaheri; Ferran Barbe; Francisco Campos-Rodriguez; Jerome A Dempsey; Rami Khayat; Sogol Javaheri; Atul Malhotra; Miguel A Martinez-Garcia; Reena Mehra; Allan I Pack; Vsevolod Y Polotsky; Susan Redline; Virend K Somers
Journal:  J Am Coll Cardiol       Date:  2017-02-21       Impact factor: 24.094

6.  Extracellular Vesicles Derived from Intermittent Hypoxia-Treated Red Blood Cells Impair Endothelial Function Through Regulating eNOS Phosphorylation and ET-1 Expression.

Authors:  Lu Peng; Yu Li; Xinwei Li; Yunhui Du; Linyi Li; Chaowei Hu; Jing Zhang; Yanwen Qin; Yongxiang Wei; Huina Zhang
Journal:  Cardiovasc Drugs Ther       Date:  2020-11-26       Impact factor: 3.727

7.  Associations between sleep apnea risk and cardiovascular disease indicators among Chinese and Korean Americans.

Authors:  Brittany N Morey; Soomin Ryu; Yuxi Shi; Susan Redline; Ichiro Kawachi; Sunmin Lee
Journal:  Sleep Epidemiol       Date:  2022-07-22

8.  Association between sleep-disordered breathing and lower extremity artery disease: a meta-analysis.

Authors:  Yuhong Chen; Xiaocheng Li; Liming Zhao; Gang Wu
Journal:  Sleep Breath       Date:  2020-05-12       Impact factor: 2.816

9.  Haemin attenuates intermittent hypoxia-induced cardiac injury via inhibiting mitochondrial fission.

Authors:  Qian Han; Guihua Li; Mary SiuMan Ip; Yuelin Zhang; Zhe Zhen; Judith ChoiWo Mak; Nuofu Zhang
Journal:  J Cell Mol Med       Date:  2018-03-07       Impact factor: 5.310

10.  Association of sleep problems with neuroendocrine hormones and coagulation factors in patients with acute myocardial infarction.

Authors:  Roland von Känel; Mary Princip; Jean-Paul Schmid; Jürgen Barth; Hansjörg Znoj; Ulrich Schnyder; Rebecca E Meister-Langraf
Journal:  BMC Cardiovasc Disord       Date:  2018-11-21       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.